The antiviral drug tecovirimat (TPOXX) failed to alleviate symptoms of mpox in a trial in the Democratic Republic of the Congo, disappointing health officials.
Lori Dodd stated that NIAID shared the initial results due to the urgent need for evidence on tecovirimat's effectiveness against mpox amid a global health emergency.
The mpox outbreak in Central Africa has resulted in 20,720 confirmed or suspected cases and 582 deaths this year, according to the Africa CDC.
WHO launched a six-month plan costing $135 million to enhance surveillance and access to testing and vaccines, aiming to control and stop the outbreak.
Collection
[
|
...
]